- The shares of McKesson Corporation (NYSE: MCK) have received a $270 price target from Argus. These are the details.
The shares of McKesson Corporation (NYSE: MCK) have received a $270 price target from Argus. And Argus analyst David Toung raised the price target from $230 while maintaining a “Buy” rating on the company shares following the second-quarter earnings.
Toung noted that the company beat expectations for the quarter and raised its FY22 guidance. And Toung is anticipating stronger top-line growth in their core pharmaceutical distribution business in FY22.
This was helped by more normal levels of primary care visits and related diagnostics — which should drive higher prescription drug volume. Plus Toung added that based on the updated guidance, he is also raising his FY22 EPS view to $22.50 from $20.25.
Disclaimer: This content is intended for informational purposes. Before making any investment, you should do your own analysis.